Skip to content

Clinical trials

Prostatic Hyperplasia trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Prostatic Hyperplasia Country / region: China Clear all

51 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20052
20062
20071
20102
20133
20141
20161
20172
20181
20191
20203
20212
20222
20233
20246
20256
202611

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Recruiting11
Not yet recruiting10
Unknown status10
Terminated3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Chinese PLA General Hospital4
Hospital Authority, Hong Kong4
GlaxoSmithKline3
Boston Scientific Corporation2
Fuzhou General Hospital2
Guang'anmen Hospital of China Academy of Chinese Medical Sciences2
Qing Yuan2
Shanghai Changzheng Hospital2
Shanghai East Hospital2
Shanghai Huilun Pharmaceutical Co., Ltd.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Prostatic Hyperplasia51
Lower Urinary Tract Symptoms11
Prostatic Neoplasms6
Urinary Retention3
Erectile Dysfunction2
Acute Disease1
Cardiovascular Diseases1
Cholecystitis1
Coronary Artery Disease1
Diabetes Mellitus1

Trials

Showing 76 to 51 of 51. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.